Is Eiger BioPharmaceuticals, Inc. (EIGRQ) a Buy, Sell, or Hold?
OTC : EIGRQ
Eiger BioPharmaceuticals, Inc. — Competitors
$8.5 USD
$0.5 (6.25%)
- Volume
- 725
- Average Volume
- 8.26K
- Market Capitalization
- $12.59M
- P/E Ratio
- -0.17
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $16.00
- Year Low
- $1.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.71
EIGRQ vs. The Competition
| Properties | EIGRQ | AVEFF | BNOEF | CRPOF |
|---|---|---|---|---|
| Market Cap | $12.59M | $13.35M | $8.81M | $13.31M |
| Shares Outstanding | $1.48M | $2.97B | $1.47B | $78.29M |
| P/E Ratio | -0.17 | -15.71 | -0.3 | -3.74 |
| EPS | -50.78 | -0.0 | -5.26 | -0.06 |
| Day Low | 8 | 0.003 | 0.0034 | 0.17 |
| Day High | 8.5 | 0.0045 | 0.006 | 0.17 |
| Year Low | 1.1 | 0.003 | 0.0013 | 0.115 |
| Year High | 16 | 0.0045 | 0.055 | 0.399 |
| Average Price 50 | 11.27 | 0.0045 | 0.0107546 | 0.18412 |
| Average Price 200 | 6.94462 | 0.0045 | 0.019798 | 0.203735 |
| Volume | 725 | 300K | 72739 | 6000 |
| Average Volume | - | - | - | - |